2025
article
OpenAlex
Johannes Starp, Antonia Leonhardt, Michael Zöller, Christina Scharf et autres
de, au
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Lea Marie Schatz, Sebastian Greppmair, Alexandra K. Kunzelmann, Johannes Starp et autres
OBJECTIVES: Piperacillin (PIP)/tazobactam is a frequently prescribed antibiotic; however, over- or underdosing may contribute to toxicity, therapeutic failure, and development of antimicrobial resistance. An external evaluation of 24 published PIP-models demonstrated that model-informed precision dosing (MIPD) can enhance target attainment. Employing various …
de
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Sebastian Greppmair, Alexander Brinkmann, Anka C. Roehr, Otto Roman Frey et autres
PURPOSE: Inadequate piperacillin (PIP) exposure in intensive care unit (ICU) patients threatens therapeutic success. Model-informed precision dosing (MIPD) might be promising to individualize dosing; however, the transferability of published models to external populations is uncertain. This study aimed to externally evaluate the …
de, ca, at
(code pays fourni par la source)
2023
article
OpenAlex
Ola Ramadan, Lea Marie Schatz, Ingeborg Alijda van den Heuvel, Katja Masjosthusmann et autres
BACKGROUND: Meropenem is a carbapenem antibiotic often used in pediatric intensive care units due to its broad spectrum of activity. Therapeutic drug monitoring (TDM) is a useful tool to increase the effectiveness of meropenem by adjusting the dose based on plasma levels; …
de, us
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Lea Marie Schatz, Alexander Brinkmann, Anka C. Röhr, Otto Roman Frey et autres
and Bayesian dosing MPE within |2%|, MAPE <30%). Our study revealed the O'Jeanson model as the best-predicting model for intermittent infusion. However, most of the selected PopPK models are suitable for MIPD in CRRT patients when one therapeutic drug monitoring sample is …
de
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Simon Kallee, Christina Scharf, Lea Marie Schatz, Michael Paal et autres
Voriconazole (VRC) is used as first line antifungal agent against invasive aspergillosis. Model-based approaches might optimize VRC therapy. This study aimed to investigate the predictive performance of pharmacokinetic models of VRC without pharmacogenetic information for their suitability for model-informed precision dosing. Seven …
de
(code pays fourni par la source)
2022
article
OpenAlex
Lea Marie Schatz, Michael Zöller, Christina Scharf, Uwe Liebchen
de
(code pays fourni par la source)